STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk.

While the medical world is melting down from the absolute apocalypse that is RFK Jr., it's good to celebrate that (at least ...

Currently, the researchers are using CRISPR-TO to move endogenous RNAs – RNA molecules that are naturally produced within the ...

For years, the CRISPR-Cas9 genome technology has been reshaping genetic engineering, a precision tool to transform everything from agriculture to medicine. With its incredible efficiency ...

Prime was formed in 2019 around a CRISPR-based technology from biochemist ... Novavax finally received full FDA approval for its Covid-19 vaccine over the weekend, but it was limited to people ...

The Food and Drug Administration unveiled plans Tuesday to narrow its approval for updated coronavirus vaccines to older adults and people with at least one health condition that puts them at high ...

Trident Homes is utilizing 3D-printing technology to build affordable, energy-efficient homes in Topeka, KS. These concrete homes are projected to be built in 4-6 months, compared to 9-12 months ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious ...

Researchers have developed a 3D micro-printed sensor for highly sensitive on-chip biosensing. The sensor, which is based on a ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

The FDA has lost no time in approving Vertex Pharma and CRISPR Therapeutics pioneering gene-editing therapy Casgevy for its second use, approving the drug for transfusion-dependent beta ...